Promino Nutritional Sciences Inc.
MUSL
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 610.60K | 373.00K | 181.70K | 69.30K | 95.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 610.60K | 373.00K | 181.70K | 69.30K | 95.90K |
| Cost of Revenue | 371.90K | 282.50K | 114.60K | 358.90K | 55.60K |
| Gross Profit | 238.70K | 90.50K | 67.10K | -289.60K | 40.40K |
| SG&A Expenses | 607.90K | 669.50K | 537.70K | -743.20K | 1.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 981.60K | 955.80K | 654.10K | -357.80K | 1.47M |
| Operating Income | -371.00K | -582.80K | -472.40K | 427.10K | -1.38M |
| Income Before Tax | 144.90K | -947.20K | -373.20K | 126.30K | -1.35M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 144.90K | -947.20K | -373.20K | 126.30K | -1.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 144.90K | -947.20K | -373.20K | 126.30K | -1.35M |
| EBIT | -371.00K | -582.80K | -472.40K | 427.10K | -1.38M |
| EBITDA | -- | -- | -- | 431.40K | -1.37M |
| EPS Basic | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 136.39M | 136.05M | 118.38M | 114.70M | 99.93M |
| Average Diluted Shares Outstanding | 136.39M | 136.05M | 118.38M | 114.70M | 99.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |